CERo Therapeutics Correlations
| CERO Stock | 0.06 0.01 19.00% |
The current 90-days correlation between CERo Therapeutics and Awilco Drilling PLC is 0.11 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CERo Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CERo Therapeutics Holdings, moves in either direction, the perfectly negatively correlated security will move in the opposite direction.
CERo Therapeutics Correlation With Market
Significant diversification
The correlation between CERo Therapeutics Holdings, and DJI is 0.02 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings, and DJI in the same portfolio, assuming nothing else is changed.
CERo |
Moving together with CERo Stock
Moving against CERo Stock
| 0.66 | PFE | Pfizer Inc Fiscal Year End 4th of February 2025 | PairCorr |
| 0.63 | LLY | Eli Lilly | PairCorr |
| 0.56 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
| 0.55 | VALN | Valneva SE ADR | PairCorr |
| 0.53 | INBX | Inhibrx Symbol Change | PairCorr |
| 0.47 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
| 0.45 | IMAB | I Mab | PairCorr |
| 0.41 | GNFT | Genfit | PairCorr |
| 0.4 | ERNA | Eterna Therapeutics | PairCorr |
| 0.32 | FLGC | Flora Growth Corp | PairCorr |
| 0.76 | ABBV | AbbVie Inc | PairCorr |
| 0.72 | MRVI | Maravai Lifesciences | PairCorr |
| 0.55 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.55 | AMGN | Amgen Inc | PairCorr |
| 0.52 | AKAN | Akanda Corp | PairCorr |
| 0.51 | SXTPW | 60 Degrees Pharmaceu | PairCorr |
| 0.32 | MBIO | Mustang Bio | PairCorr |
| 0.66 | ARDX | Ardelyx | PairCorr |
| 0.56 | BCDA | Biocardia | PairCorr |
| 0.51 | TFFP | Tff Pharmaceuticals | PairCorr |
| 0.51 | TTOO | T2 Biosystms | PairCorr |
| 0.5 | APGE | Apogee Therapeutics, | PairCorr |
| 0.49 | TCBPW | TC BioPharm plc | PairCorr |
Related Correlations Analysis
| -0.78 | 0.26 | -0.29 | 0.0 | -0.68 | 0.52 | AWLCF | ||
| -0.78 | -0.37 | 0.33 | 0.0 | 0.65 | -0.77 | DKDRF | ||
| 0.26 | -0.37 | 0.49 | 0.0 | -0.07 | 0.5 | NE | ||
| -0.29 | 0.33 | 0.49 | 0.0 | 0.33 | -0.13 | SDRL | ||
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | IRIG | ||
| -0.68 | 0.65 | -0.07 | 0.33 | 0.0 | -0.33 | GFS | ||
| 0.52 | -0.77 | 0.5 | -0.13 | 0.0 | -0.33 | TER | ||
| Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between CERo Stock performing well and CERo Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze CERo Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| AWLCF | 0.08 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.54 | |||
| DKDRF | 1.03 | 0.27 | 0.04 | (1.80) | 1.14 | 2.89 | 22.23 | |||
| NE | 1.78 | (0.24) | 0.00 | (0.09) | 0.00 | 3.36 | 15.01 | |||
| SDRL | 1.93 | 0.08 | (0.01) | (1.55) | 2.10 | 3.83 | 13.86 | |||
| IRIG | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| GFS | 2.06 | (0.05) | 0.04 | 0.07 | 2.22 | 4.70 | 18.30 | |||
| TER | 1.85 | (0.17) | 0.00 | (0.03) | 0.00 | 3.37 | 16.20 |
CERo Therapeutics Corporate Executives
Elected by the shareholders, the CERo Therapeutics' board of directors comprises two types of representatives: CERo Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CERo. The board's role is to monitor CERo Therapeutics' management team and ensure that shareholders' interests are well served. CERo Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CERo Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Daniel MD | CTO Founder | Profile | |
| Lawrence MD | Cofounder Board | Profile | |
| Charles Carter | Treasurer CFO | Profile |